These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 9360305)
1. Functional activation of antibodies on modification with Pd(II) coproporphyrin I N-Hydroxysuccinimide ester. Mel'nikova YaI ; Kravchuk ZI; Preygerzon VA; Martsev SP Biochemistry (Mosc); 1997 Aug; 62(8):924-7. PubMed ID: 9360305 [TBL] [Abstract][Full Text] [Related]
2. Modification of monoclonal and polyclonal IgG with palladium (II) coproporphyrin I: stimulatory and inhibitory functional effects induced by two different methods. Martsev SP; Preygerzon VA; Mel'nikova YI; Kravchuk ZI; Ponomarev GV; Lunev VE; Savitsky AP J Immunol Methods; 1995 Oct; 186(2):293-304. PubMed ID: 7594629 [TBL] [Abstract][Full Text] [Related]
3. [A stable conformer of IgG, prepared by an acidic influence: study by calorimetry, binding of the C1q complement component, and monospecific anti-IgG]. Kravchuk ZI; Vlasov AP; Liakhnovich GV; Martsev SP Biokhimiia; 1994 Oct; 59(10):1458-77. PubMed ID: 7819387 [TBL] [Abstract][Full Text] [Related]
4. [Modification of a disulfide in the hinge region of rabbit IgG and study of the interaction of polyvalent ferritin antigen, protein A, and anti-IgG]. Lepesheva GI; Martsev SP Biokhimiia; 1992 Jul; 57(7):1089-99. PubMed ID: 1391214 [TBL] [Abstract][Full Text] [Related]
5. [IgG, modified with coproporphyrin I and the possibility of direct measurement of the antigen-antibody complex]. Lepesheva GI; Turko IV; Shestakov VL; Chashchin VL Biokhimiia; 1993 Jun; 58(6):938-43. PubMed ID: 8364116 [TBL] [Abstract][Full Text] [Related]
6. Influence of linker unit on performance of palladium(II) coproporphyrin labelling reagent and its bioconjugates. Soini AE; Yashunsky DV; Meltola NJ; Ponomarev GV Luminescence; 2003; 18(3):182-92. PubMed ID: 12830817 [TBL] [Abstract][Full Text] [Related]
8. [Oxidative iodination of rabbit IgG: localization of markers in an Fc-fragment and effects of modification]. Zhorov OV; Kirillova NM; Martsev SP Biokhimiia; 1991 May; 56(5):828-38. PubMed ID: 1747412 [TBL] [Abstract][Full Text] [Related]
9. [Monoclonal antibodies to human spleen ferritin. II. Localization of epitopes and quantitative parameters of antigen binding]. Mel'nikova IaI; Lunev VE; Preĭgerzon VA; Luneva NM; Koshkin SA; Rodionov MA; Martsev SP Biokhimiia; 1993 May; 58(5):759-71. PubMed ID: 8338888 [TBL] [Abstract][Full Text] [Related]
10. Monofunctional derivatives of coproporphyrins for phosphorescent labeling of proteins and binding assays. O'Riordan TC; Soini AE; Papkovsky DB Anal Biochem; 2001 Mar; 290(2):366-75. PubMed ID: 11237341 [TBL] [Abstract][Full Text] [Related]
11. Identification of important residues in metal-chelate recognition by monoclonal antibodies. Delehanty JB; Jones RM; Bishop TC; Blake DA Biochemistry; 2003 Dec; 42(48):14173-83. PubMed ID: 14640685 [TBL] [Abstract][Full Text] [Related]
15. Preparation and characterization of methotrexate-immunoglobulin conjugates. Ghosh MK; Kildsig DO; Mitra AK Drug Des Deliv; 1989 Jan; 4(1):13-25. PubMed ID: 2789065 [TBL] [Abstract][Full Text] [Related]
16. Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high-mannose, hybrid, and complex types. Kanda Y; Yamada T; Mori K; Okazaki A; Inoue M; Kitajima-Miyama K; Kuni-Kamochi R; Nakano R; Yano K; Kakita S; Shitara K; Satoh M Glycobiology; 2007 Jan; 17(1):104-18. PubMed ID: 17012310 [TBL] [Abstract][Full Text] [Related]
17. The crystal structure of the pathogenic collagen type II-specific mouse monoclonal antibody CIIC1 Fab: structure to function analysis. Uysal H; Sehnert B; Nandakumar KS; Böiers U; Burkhardt H; Holmdahl R; Thunnissen MM Mol Immunol; 2008 Apr; 45(8):2196-204. PubMed ID: 18241923 [TBL] [Abstract][Full Text] [Related]
18. Crystallographic structure of an intact IgG1 monoclonal antibody. Harris LJ; Skaletsky E; McPherson A J Mol Biol; 1998 Feb; 275(5):861-72. PubMed ID: 9480774 [TBL] [Abstract][Full Text] [Related]
19. The effects of domain deletion, glycosylation, and long IgG3 hinge on the biodistribution and serum stability properties of a humanized IgG1 immunoglobulin, hLL2, and its fragments. Leung SO; Qu Z; Hansen HJ; Shih LB; Wang J; Losman MJ; Goldenberg DM; Sharkey RM Clin Cancer Res; 1999 Oct; 5(10 Suppl):3106s-3117s. PubMed ID: 10541351 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of an immunoassay for human-specific quantitation of therapeutic antibodies in serum samples from non-human primates. Stubenrauch K; Wessels U; Lenz H J Pharm Biomed Anal; 2009 May; 49(4):1003-8. PubMed ID: 19250787 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]